John Yan, PhD, from Takeda Pharmaceutical Company presented an ultrasensitive assay format for detecting PD biomarkers in cell and xenograft tumors at the inaugural Powering Precision Health Summit 2016.
This webinar describes a groundbreaking new technique published recently in Analytical Chemistry for measuring single cancer cells. The study, conducted by Dr. David Walt and his research group at Tufts University, demonstrates that the ultrasensitive Simoa technology makes it possible to quantify…
We describe the use of single molecule arrays (Simoa) for the multiplex detection of proteins at very low concentrations in this webinar. We also provide an overview of the Simoa technology - which is capable of providing a 1000-fold improvement in sensitivity to proteins over conventional assays.
TBIs are common in military personnel and civilians, placing these individuals at high risk for neurological deficits. The reasons why some individuals are at higher risk for these symptoms and deficits remains largely unknown. This webinar explores the topic further.